Reneo Pharmaceuticals
  • Who We Are
    • About Us
    • Our Work
    • Leadership
    • Careers
  • Programs
    • REN001 Overview
    • Pipeline
    • Clinical Trials
    • Presentations and Publications
  • Patients
    • PMMs
    • FAODs
    • McArdle
    • Patient Stories
    • Clinical Research
  • NEWS
  • Investors
    • Corporate Overview
    • News
    • Stock Information
    • Financials & Filings
    • Corporate Governance
      • Leadership
      • Board of Directors
      • Committee Composition
      • Documents and Charters
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Contact Investor Relations
  • Contact
Menu
  • Who We Are
    • About Us
    • Our Work
    • Leadership
    • Careers
  • Programs
    • REN001 Overview
    • Pipeline
    • Clinical Trials
    • Presentations and Publications
  • Patients
    • PMMs
    • FAODs
    • McArdle
    • Patient Stories
    • Clinical Research
  • NEWS
  • Investors
    • Corporate Overview
    • News
    • Stock Information
    • Financials & Filings
    • Corporate Governance
      • Leadership
      • Board of Directors
      • Committee Composition
      • Documents and Charters
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Contact Investor Relations
  • Contact

Investors

Reneo thanks the following investors for their continued support:

Have a Question?

If you have any question or comment, please visit our Contact Us page.
CONTACT US

Latest News

Reneo Pharmaceuticals Raises $95 Million in Series B Financing, Co-led by Novo Ventures and Abingworth

December 9, 2020
Learn More

Reneo Receives Orphan Drug Designations from the EMA for REN001 for the Treatment of LCHAD Deficiency and MELAS Syndrome and Moves Forward with Clinical Trials

September 9, 2020
Learn More

Restoring Cellular Power Outages: A New Drug Candidate to Treat Mitochondrial Disease

August 12, 2020
Learn More
VIEW ALL NEWS

Company

Who We Are
Programs
Patients
News
Investors
Contact
Links
US Privacy Policy
EU Privacy Policy
Careers
© Copyright 2023 – Reneo Pharmaceuticals, Inc.